The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Abstract
Introduction
New indications for psychotropic drugs
Alprazolam in panic disorder
Clonazepam in mania
Clonazepam in panic disorder
Rebound anxiety, supersensitivity psychosis and new indications for benzodiazepines
Lithium-tryptophan in affective disorders
Tomoxetine in major depression and attention-deficit hyperactivity disorder
Duloxetine in major depression and neuropathic pain
Bupropion in depression and smoking cessation
Zimeldine in OCD and no crossover hypersensitivity reactions with other SSRIs
Fluoxetine in major depression and OCD
Sertraline in OCD
Risperidone in Tourette's syndrome
Gabapentin in anxiety and insomnia disorders
Conclusion
Footnote
References
Information & Authors
Information
Published In
History
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).